Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study

Purpose: Pulmonary tuberculosis (TB) is a worldwide life-threatening infection. Therecommended anti-TB regimen contains oral administration of classical first-line drugs suchas rifampin for 6-24 months which often leads to low patient compliance due to high adverseeffects; therefore, lung localized...

Descripción completa

Detalles Bibliográficos
Autores principales: Parhizkar, Elahehnaz, Sadeghinia, Delaram, Hamishehkar, Hamed, Yaqoubi, Shadi, Nokhodchi, Ali, Alipour, Shohreh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tabriz University of Medical Sciences 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106949/
https://www.ncbi.nlm.nih.gov/pubmed/35620341
http://dx.doi.org/10.34172/apb.2022.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106949/
https://www.ncbi.nlm.nih.gov/pubmed/35620341
http://dx.doi.org/10.34172/apb.2022.032

Ejemplares similares